Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1CNS 1

Conditions

Neurofibroma, Plexiform 3Neurofibromatosis 1 2Radiation Fibrosis Syndrome 1Precancerous Conditions 1Neurofibromatoses 1Nerve Sheath Neoplasms 1Myofibroma 1Lung Neoplasms 1Leiomyoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Biopsy 8Polymerase Chain Reaction 6Peripheral Blood Stem Cell Transplantation 5Epoetin Alfa 5Sulindac 4Microarray Analysis 4Gene Expression Profiling 4Cyclophosphamide 4Colposcopy 4Cetuximab 4Celecoxib 4fludarabine phosphate 3Vaginal Smears 3Selenium 3Methotrexate 3Imiquimod 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Eflornithine 3Darbepoetin alfa 3Aspirin 3Antilymphocyte Serum 3Whole-Body Irradiation 2Vitamin E 2Tacrolimus 2Radiotherapy, Intensity-Modulated 2Methylprednisolone 2Light Coagulation 2Interferon-alpha 2In Situ Hybridization, Fluorescence 2Immunohistochemistry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Precancerous Conditions × pirfenidone × Clear all
NCT00053937 2015-04-30

Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas

National Cancer Institute (NCI)

Phase 1 Completed
CNSOther neoplasm

Neurofibromatosis 1, Precancerous Conditions, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡